RMD Open : Impact Factor & More
eISSN: 2056-5933pISSN: 2056-5933
Open AccessShare this on:
Key Metrics
CiteScore 
7.1
Impact Factor
5 - 10
Scite Index
0.87 5-Year SI
SJR
Q2Immunology
SNIP
1.72
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on RMD Open
RMD Open Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | BMJ PUBLISHING GROUP |
| Language | English |
| Frequency | Semi-annual |
| Article Processing Charges | GBP 2060 |
| Publication Time | 14 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | EULAR |
| Frequency | Semi-annual |
| Publication Start Year | 2015 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC, CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in RMD Open ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in RMD Open
Ultrasound-based withdrawal of biologics in rheumatoid arthritis (RA-BioStop).
- 7 Aug 2026
- RMD open
Influence of initial axial involvement on the phenotypic evolution of axial spondyloarthritis: 10-year data from the DESIR cohort
- 5 Aug 2026
- RMD Open
Therapeutic approaches for difficult-to-treat rheumatoid arthritis: a systematic literature review of current evidence
- 4 Aug 2026
- RMD Open
Effectiveness and safety of interleukin 6 receptor inhibitors versus conventional immunomodulatory therapy in steroid-refractory polymyalgia rheumatica
- 3 Aug 2026
- RMD Open
Understanding fibromyalgia beyond pain: emotional imbalance and the case for compassionate care
- 30 Jul 2026
- RMD Open
Prognostic value of antiphospholipid antibodies in pregnancy outcomes in systemic lupus erythematosus
- 30 Jul 2026
- RMD Open
Ultrasound-based withdrawal of biologics in rheumatoid arthritis (RA-BioStop).
- 7 Aug 2026
- RMD open
Influence of initial axial involvement on the phenotypic evolution of axial spondyloarthritis: 10-year data from the DESIR cohort
- 5 Aug 2026
- RMD Open
Therapeutic approaches for difficult-to-treat rheumatoid arthritis: a systematic literature review of current evidence
- 4 Aug 2026
- RMD Open
Effectiveness and safety of interleukin 6 receptor inhibitors versus conventional immunomodulatory therapy in steroid-refractory polymyalgia rheumatica
- 3 Aug 2026
- RMD Open
Understanding fibromyalgia beyond pain: emotional imbalance and the case for compassionate care
- 30 Jul 2026
- RMD Open
Prognostic value of antiphospholipid antibodies in pregnancy outcomes in systemic lupus erythematosus
- 30 Jul 2026
- RMD Open
FAQs on RMD Open
How long has RMD Open been actively publishing? 
What is the publishing frequency of RMD Open?
How many articles did RMD Open publish last year?
What is the eISSN & pISSN for RMD Open?
What is Citescore for RMD Open?
What is SNIP score for RMD Open?
What is the SJR for RMD Open?
Who is the publisher of RMD Open?
